Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Alpha Lipoic Acid Combined With Myo-Inositol With or Without Metformin in Non-Diabetic Women With PCOS
NCT07630779Phase 3Recruiting
- Sponsor
- Beni Suef University
- Start
- Mar 2026
- Primary completion
- Sep 2026
- Countries
- 1
01
Overview
Phase 3, randomised trial of alpha-lipoic acid and liquid metformin (Aspargo Labs) in polycystic ovary syndrome (PCOS) (3 arms), sponsored by Beni Suef University. Primary endpoints: Ovulation Rate at 6 months and Menstrual Cycle Regularity at 6 months. Started Mar 2026; status: recruiting.
02
Drugs
alpha-lipoic acidliquid metformin (Aspargo Labs)
03
Conditions
polycystic ovary syndrome (PCOS)
Beyond the preview
Go deeper on NCT07630779.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07630779.